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Abstract
The reporting quality of Observational Studies (OSs) is an important measure of their over-
all quality. We aim to assess the reporting quality of OSs of Shiraz University of Medical 
Sciences (SUMS) in Iran in the years 2012–2015, using Strengthening the Reporting of 
Observational Studies checklist. Systematic online search was performed. A random sam-
ple of SUMS affiliated published articles was selected. Articles were appraised and scored 
by two reviewers. Variables such as the study design, publication year, journals’ impact 
factor etc. were retrieved and their correlation with the articles’ scores was assessed. Out of 
4297 published articles during 2012–2015, 1742 (40.5%) were OSs of which we assessed 
171 (~ 10%) studies. Among these, 87 (50.9%), 74 (43.3%) and 10 (5.8%) articles had a 
cross-sectional, case–control and cohort design, respectively. Overall score of the report-
ing quality was 79% ± 0.01. It was at 81% ± 0.1, 77% ± 0.01 and 83% ± 0.02 for cross-sec-
tional, case–control and cohort studies, respectively. A significant correlation was observed 
between the study design and the score for the reporting quality (P = 0.015). Reporting of 
“flow-diagram” (5%), “sources of bias” (28%) and “study size calculation” (30%) were the 
most missed items. Although the overall reporting quality of OSs was found to be at an 
acceptable rate, there are points of concern regarding some of the most important items 
that deserve the attention of authors as well as reviewers and editors.
Keywords Observational studies · STROBE statement · Quality of reporting · Shiraz 
University of Medical Sciences · Iran
Introduction
Observational Studies (OSs) are the most reliable source of information on the epidemi-
ology, etiology and prognosis of diseases (Hoppe et  al. 2009). They lead to systematic 
reviews that better interpret their results and have their own assessment tools (Tsakiridis 
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et al. 2019). However, OSs are prone to a variety of biases, such as the recall, selection, and 
information bias, as well as confounding, etc. (Hammer et al. 2009; Bero et al. 2018). Ade-
quate reporting helps readers to critically appraise a study and low quality studies might 
lead to inappropriate decisions leading to catastrophic results. It has been observed that 
the reporting of OSs is usually not clear and detailed enough (von Elm et al. 2007), espe-
cially in parts like the reporting of confounding variables (Glasziou et al. 2014; Pouwels 
et al. 2016) and potential biases (Vandenbroucke et al. 2007). Accordingly, a group of 10 
renowned researchers from 6 different countries developed a checklist called the Strength-
ening the Reporting of Observational Studies (STROBE) checklist in 2007. The STROBE 
statement helps authors to “improve the reporting of observational studies” and “facilitates 
the critical appraisal and the interpretation of studies by reviewers, journal editors and 
readers” (Vandenbroucke et al. 2007).
In Iran, universities of medical sciences are responsible for training biomedical research-
ers as well as conducting biomedical research and monitoring healthcare. Therefore, the 
assessment of studies affiliated to medical universities provides us with an understanding 
regarding the quality of their work. This can promote the quality of research and healthcare 
policies in the long term, if proper actions are taken. Shiraz University of Medical Sciences 
(SUMS) is a high-ranking university in Iran and to date, no study has evaluated the report-
ing quality of OSs in this university. Therefore, the results of this study have strong impli-
cations for policy makers in this university. In the present study, we aimed to assess the 
reporting quality of OSs published by the researchers affiliated to SUMS using STROBE 
checklist as our assessment tool.
Methods
In this cross-sectional study, we examined the reporting quality of 171 OSs affiliated to 
SUMS in 2012–2015 time period. In order to do so, we initially assessed all the published 
articles in the mentioned timeframe and categorized them based on their study design. 
Subsequently, we selected 171 OSs from the total number of OSs and evaluated them in 
terms of their reporting quality. The following steps were taken.
Search strategy
Systematic online search was performed in the international databases including Scopus, 
Web of Science, Embase, PubMed/MEDLINE, Cochrane Library, Google Scholar, and 
national databases such as Science Information Database (SID), Iran Medex and Magiran, 
using the keyword “Shiraz University of Medical Sciences” both in the affiliation section 
and the body of documents. Online search results were merged with the list of articles col-
lected by SUMS’s scientometry committee. The search included all the studies from March 
20th of 2012 until March 20th of 2015.
Selection of articles
After excluding the duplicate articles, we found 4297 articles. In the process of dedu-
plication, we included the more recent duplicated publications. Reports without full 
text were purchased via the university library. As the designs of most studies were not 
obvious in the title, two reviewers categorized the articles based on their study design 
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and type of document. The categories included randomized clinical trials (RCTs), non-
RCT interventional studies, case–controls, cross-sectionals, cohorts, qualitative studies, 
reviews, case reports, case series, short communications, and editorials. We used con-
venient sampling and included a random sample of 171 studies (~ 10%) out of the total 
number of observational studies (1742) in the specified timeframe. Out of 171 articles, 
case–control, cross-sectional and cohort studies were selected, using a stratified random 
sampling method (Fig. 1).
To ensure the reliability and validity of quality assessments, two reviewers were 
trained similarly. Initially, a random sample of 10 studies was assessed simultaneously 
by the two reviewers to obviate any ambiguities regarding the STROBE items and 
how to use them for evaluating the articles. Any uncertainty was clarified via discuss-
ing them with a third person (methodologist). Then, pilot assessment of 30 randomly 
selected articles was performed separately by each reviewer and their concordance 
was measured. The inter-rater reliability was calculated for these random samples with 
interclass correlation coefficient. After reaching acceptable concordance (90%, 95% CI 
67–97, P < 0.001), the evaluation of 171 studies was commenced. While appraising the 
articles, the two reviewers were blinded to the authors’ names and the names of the 
journals in order to avoid information bias.
9124 articles published from 2012 to 2014
2460 articles in 
2012
3430 arcles in 
2014
3234 articles in 
2013
9124 articles assessed for eligibility
4297 articles
remaining
4827
duplicated
articles
excluded 
Non observational studies (N=2555) excluded:
RCTs (540)
Other types of trials (N=920)
Editorials (N=243)
Case reports and case series (N=304)
Systemac reviews (N=298)
Qualitave and Mixed methodology studies (130)
Short communicaons (N=120)
1742 observational studies
294 Case 
Control 
Studies
1363 Cross 
Seconals 
Studies
85 Cohort 
Studies
87 Cross
Seconals
Studies finally 
analyzed
74 Case
Control
Studies finally 
analyzed
10 Cohort
Studies finally 
analyzed
Fig. 1  Flow diagram illustrating the process of selection of 171 observational studies
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Instrument
We used STROBE as the assessment tool. The STROBE checklist is comprised of 22 
items related to the title and abstract (item 1), introduction (items 2 and 3), methods (items 
4–12), results (items 13–17), discussion (items 18–21) and information on funding (item 
22). Eighteen items are common to all three categories of OSs while 4 items have subcat-
egories that are related to a specific type of OS (von Elm et al. 2007). Similar to many pre-
vious studies and in order to facilitate the scoring, we further subcategorized some items 
(e.g. item No.5 becomes 5a, 5b, 5c, 5d) and developed 53 smaller items with equal weights 
(Table 1). If the item was mentioned in the appropriate section of the article, it received 
one point and if not, zero point was given. Some items might not have been applicable to a 
specific article; hence, the items were not taken into account. We arbitrarily labeled items 
with the Average Reporting Percentage (ARP) > 70% as “sufficiently reported”, items with 
ARP 40–70% as “insufficiently reported” and items < 40% as “poorly reported”. During the 
appraisal process, our methodologist was consulted whenever the two reviewers were not 
certain how to score an item.
Scoring and correlations
The Average Reporting Percentage (ARP) of items—based on STROBE checklist—in each 
article was calculated. In addition, the ARP of each item was calculated among all the 
articles. We also calculated the ARP in different sections of articles including “title and 
abstract”, “introduction”, “methods”, “results”, “discussion and conclusion” in different 
study designs. Subsequently, we measured the correlation between the ARP and the fol-
lowing variables: the article’s publication year, the type of OS, the field of study-clinical 
medicine, dentistry, basic sciences and others-, the number of authors, whether the first 
author was a faculty member or not, the last impact factor of the journal, whether the arti-
cle was written in English or Persian, whether it was the result of an international or inter-
university collaboration or not, and whether it was the result of a dissertation or not. The 
data regarding the authors and journals was obtained from the Resource Finder website of 
the Health Ministry.
Statistical analysis
The collected data were analyzed by SPSS 22 software. Descriptive statistics including fre-
quency and relative frequency were calculated and Mann–Whitney U test, Kruskal–Wal-
lis test and Pearson correlation were used to determine whether a significant correlation 
existed between the ARPs in different types of OSs and its association with the other stud-
ied variables. P < 0.05 was considered to be statistically significant.
Results
In this study, 4297 SUMS-affiliated studies published in 2012–2015 timeframe were 
assessed. As shown in Fig.  2, the most prevalent study design was the cross-sectional 
(1363, 31.7%), followed by non-RCT interventional studies (920, 21.4%) and RCTs (540, 
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12.5%). Among 171 OSs, the number (%) of cross-sectional, case–control and cohort stud-
ies was 87 (50.9%), 74 (43.3%) and 10 (5.8%), respectively (Fig.  1). Of all the OSs, 8 
(4.6%) were the product of international collaboration. Fifty-two (30.4%) were the result 
of students ‘ dissertations and 27 (15.7%) were written in Persian. Regarding the articles’ 
field of study, articles in the field of clinical medicine comprised the majority of articles 
(133/171, 78%). Dentistry, basic sciences and other categories accounted for 12 (7%), 8 
(4.6%) and 18 (10.5%) of all 171 OSs.
Around 69% of the items in our study showed sufficient reporting (ARP > 70%), 
17% showed insufficient reporting (ARP = 40–70%) and 13% showed poor reporting 
(ARP < 40%). The ARP of each STROBE item in OSs and its three subtypes are shown 
in Table  1. The ARP (± SE) among all OSs was found to be 79% ± 0.01. The ARP in 
the cross-sectional, case–control and cohort studies was 81% ± 0.01, 77% ± 0.01 and 
83% ± 0.02, respectively. Cross-sectional studies exhibited a significantly higher ARP in 
comparison to case–control studies (P = 0.015).
The ARP in the methods section of OSs was 0.78 ± 0.14, which differed significantly 
(P = 0.008) in the three types of OSs. The ARP in the methods section was significantly 
higher in the cohort and cross-sectional studies compared with case–control studies 
(P = 0.039 and 0.005). As for the publication year, articles published during March 20th 
of 2013 to March 20th of 2014 were reported better than articles from March 20th of 2012 
to March 20th of 2013 (P = 0.034). In addition, articles from March 20th of 2014 to March 
20th of 2015 were reported better than articles from March 20th of 2012 to March 20th of 
2013(P = 0.000) (Table 2).
The association between the ARP and some variables related to the journal and 
authors was evaluated as well. Field of study had a significant association with the ARP 
(P = 0.040); articles in the field of clinical medicine were better reported than those related 
to basic sciences (P = 0.031). Furthermore, articles that were the result of an international 
31.7%
21.4%
12.5%
7%
6.9%
6.8%
5.6%
3% 2.8%
2%
cross seconal
non-RCT intervenonal studies
RCTs
case reports and case series
systemac reviews
case control
editorials
qualitave and mixed methodology
studies
short communicaons
cohort
Fig. 2  The distribution of study designs among 4297 articles
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collaboration (8/171, 4.7%) had significantly higher reporting percentages than those with-
out international collaboration (P = 0.003). The following variables did not show a sig-
nificant correlation with the ARP: The last impact factor of the journal, the language of 
the article, the number of authors, whether the first author was a faculty member or not, 
whether the article was the result of an inter-university collaboration, and whether it was 
the result of a dissertation or not.
Discussion
In the present study, we evaluated the adherence of 171 OSs to STROBE items and also 
assessed the reporting of items in different article sections. The overall ARP in our study 
(79%) was close to percentages reported by previous studies (Nagarajan et al. 2018; Fung 
et al. 2009; Bastuji-Garin et al. 2013). The “introduction” and “results” sections had the 
highest ARPs among the article sections and the acceptable ARP in our study is a result of 
the high percentages in these two sections. The lowest ARPs belonged to the “discussion” 
and “title and abstract” sections, which can be attributed to inadequate reporting in items 
1a, 19a and 21, as will be discussed below. We found the reporting quality of the “meth-
ods” section to be significantly lower in case–control studies compared with cohort and 
cross-sectional studies. This is a very important flaw since the methods section is essential 
in order for readers to “judge whether the methods were adequate to provide reliable and 
valid answers, and to assess whether any deviations from the original plan were reason-
able” (Vandenbroucke et al. 2007). Therefore, attention must be paid to the reporting of the 
methods section in case–control studies.
Regarding the type of OS, cross-sectional studies were better reported than case–control 
studies. This difference can be attributed to the difference in the reporting of items in the 
methods section as mentioned above. Since case–control studies provide a great proportion 
of evidence in the field of medicine, more attention should be given to reporting these stud-
ies, especially in the methods section. Contrary to our results, in the study by Nagarajan 
et al. in which the reporting quality of OSs in Indian journals was evaluated, the ARP was 
50.5%, 49.11% and 44.39% for cross-sectional, cohort and case–control studies, respec-
tively and the differences were not statistically significant (Nagarajan et al. 2018).
Reporting “the study design in the title or abstract” helps readers to “easily identify the 
design that was used” and also helps with “the indexing of articles in electronic databases” 
(Vandenbroucke et al. 2007). The ARP of this item in our study was 53% (insufficiently 
reported), which was close to percentages from some previous studies (Bastuji-Garin et al. 
2013; Nagarajan et al. 2018). There are also studies that show this item to be well reported 
(86% and 98%) (Fung et al. 2009; Langan et al. 2010).
Table 2  Average Reporting Percentage (ARP) in different article sections
Article sections Overall ARP ± SD ARP ± SD in cross 
sectional studies
ARP ± SD in case 
control studies
ARP ± SD in 
cohort studies
Title and abstract 0.76 ± 0.25 0.78 ± 0.25 0.73 ± 0.25 0.80 ± 0.26
Introduction 0.99 ± 0.05 0.99 ± 0.05 0.99 ± 0.06 1.0 ± 0.0
Methods 0.78 ± 0.14 0.81 ± 0.15 0.74 ± 0.14 0.82 ± 0.07
Results 0.82 ± 0.17 0.84 ± 0.17 0.80 ± 0.17 0.86 ± 0.13
Discussion 0.75 ± 0.16 0.75 ± 0.17 0.75 ± 0.16 0.80 ± 0.17
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“Potential sources of bias” were reported in 28% of the evaluated articles. Cohort 
and cross-sectional studies had the highest (50%) and lowest (24%) ARP regarding this 
item. Inadequate reporting of this item is also seen in previous studies (Fung et al. 2009; 
Bastuji-Garin et al. 2013; Jeelani et al. 2014; Irani et al. 2018); hence, making it difficult 
for readers to trust the study’s conclusion (Vandenbroucke et al. 2007).
Adequate sample size augments the statistical power of the study, and authors must 
“indicate the considerations that determined the study size or sample size calculations 
if they were done” (Vandenbroucke et al. 2007). Generally, this item is underreported in 
articles ranging from 4.5–34% in various studies (Bastuji-Garin et al. 2013; Nagarajan 
et al. 2018; Langan et al. 2010). In our study, 30% of studies reported this item and the 
least ARP was amongst case controls (16%).
Use of a flow diagram was the least reported STROBE item in OSs (6%) as well as 
in case–control (7%) and cross-sectional studies (2%). This pattern is observed in most 
studies with reporting percentages ranging from 2 to 21% (Ramke et  al. 2017; Fung 
et al. 2009; Langan et al. 2010; Irani et al. 2018).
The items related to the reporting of confounding in our study were: “potential con-
founders and effect modifiers (7c)” and “information on exposures and potential con-
founders (14b)”. The ARP of these items was 80.5% in our study. This was higher than 
percentages reported by some previous studies (Pouwels et al. 2016; Groenwold et al. 
2008; Langan et al. 2010). Langan et al. (2010) had reported a mean percentage of 37% 
for item 7c. Unfortunately, the different items and sub-items adopted by different studies 
makes it difficult to accurately compare the percentages among them.
“The limitations of the study” and “the generalizability of the study results” were 
reported in 53% and 43% of studies. Sufficient reporting of these items is essential for 
the assessment of a study’s internal and external validity. The ARP observed in our 
study was close to percentages in previous studies (Nagarajan et  al. 2018; Fung et  al. 
2009; Langan et al. 2010).
Two case–control-specific items that were poorly reported were: “the rationale for 
the choice of cases and controls” and “explaining how matching of cases and controls 
was addressed”, which were reported adequately in 30% and 11% of case–control stud-
ies, respectively. The choice of cases and controls is “crucial to interpreting the results” 
and matching “ensures similarity in the distribution of potential confounding variables 
between cases and controls”. Both of these items are directly relevant to the efficiency 
of a study and their lack of reporting questions the study’s validity (Vandenbroucke 
et al. 2007).
“Addressing loss to follow-up” was a poorly reported cohort-specific item (33%). The 
validity of the study will be affected “if loss to follow-up occurs selectively in exposed 
individuals, or in persons at high risk of developing the disease” (Vandenbroucke et  al. 
2007). The underreporting of this critical item is seen in previous cohort studies (Rao et al. 
2016; Poorolajal et al. 2011).
Cross-sectional studies were the second best reported type of OSs (81%). The ARP for 
cross-sectionals in our study is slightly higher than percentages from previous studies on 
the reporting of cross-sectional studies (Ramke et al. 2017; Irani et al. 2018).
Our study indicates that the overall reporting quality of OSs affiliated to SUMS has 
improved over a 3-year period from March, 2012 to March, 2015. Similarly, Bastuji-Garin 
et  al. reported an improvement in the reporting quality of OSs between 2004 and 2010 
(Nagarajan et al. 2018) while no such improvement was observed in the study by Rao et al. 
(2016). on cohort studies between 2002 and 2013 Because of the limited timeframe of our 
study, it is difficult to draw an accurate conclusion regarding the observed positive trend.
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Regarding the articles’ field of study, we found articles in the field of clinical medicine 
to be of higher reporting quality than articles in the field of basic sciences. However, the 
high number of clinical medicine articles (133/171) and the small number of basic science 
articles (8/171) in our sample of OSs decreases the accuracy of our comparison. Since the 
quality of reporting of basic science articles, especially in methods and results sections, 
affects the reproducibility of the related research (Han et al. 2017), it is suggested that the 
reporting quality of OSs in the field of basic sciences be evaluated in a separate study.
Another studied variable that showed a significant correlation with ARP was the arti-
cle’s status regarding international co-authorship. Articles with international collaboration 
demonstrated a higher reporting quality than those without international collaboration. It 
has been reported that internationally co-authored articles are published in journals with 
higher impact factors (Low et al. 2014) and are cited more often than articles without inter-
national co-authorship (Leydesdorff and Wagner 2008). It is therefore recommended to 
take steps to initiate international research collaboration with the ultimate goal of improv-
ing the quality of research.
Regarding the relationship between the last impact factor of the journal and the quality 
of reporting of the associated article, we did not find a significant correlation. In one study, 
the impact factor of the journal was positively correlated with the reporting of some but 
not all STROBE items (Hemkens et al. 2016). However, since only few studies have been 
conducted to investigate this association, we can not draw an accurate conclusion. In our 
study, since we assessed the association between the last impact factor of the journal and 
only one of the articles in that journal, we can not say with certainty that this relationship 
does not exist.
We would like to remind and emphasize that our results reflect the reporting quality of 
studies and not the quality of the research or the study design. This is in accordance with 
recommendations from STROBE creators who stated that “STROBE statement was not 
developed as a tool for assessing the quality of published observational research”. How-
ever, transparent reporting of research leads to better assessment of their methodological 
quality and the improvement of the methodology as well as the design of the articles over 
time (von Elm et al. 2007). We highly recommend researchers to use STROBE checklist 
while writing research manuscripts and recommend university research departments to 
monitor research papers as well as educate researchers regarding transparent reporting. As 
SUMS is one of the top ten universities in Iran, the study results might be generalized to 
other Iranian universities and institutions.
Limitations and strengths
We included only published studies which may increase the risk of publication bias. 
Another limitation is related to the limited time frame of 3 years, which makes it difficult to 
assess the reporting quality of articles over time. Furthermore, in line with previous stud-
ies, we gave each STROBE item equal weight. Since some items might be more important 
than others for a specific type of OS, our reporting percentages might not be ideal.
Among the strengths of our study are the blinding of the two reviewers to the articles’ 
authors and the names of journals and the presence of inter-rater agreement in our pilot 
study. In addition, comparing reporting percentages in different study designs and different 
article sections is an advantage of this study over the previous studies.
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Conclusion
The quality of reporting of OSs assessed in this study is generally acceptable. However, 
items such as “use of a flow diagram”, “sources of bias” and “sample size calculation” 
among all OSs and “loss to follow-up” among cohort studies are poorly reported items 
that deserve the attention of authors as well as reviewers and editors.
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